Haichuan Su, PhD
Tang-Du Hospital
2
2
0
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mattias Rudebeck, PhD MSc BMedSc
Immedica Pharma AB
Shared therapeutic areas:
David R. Spigel, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Fadi Braiteh, MD
Comprehensive Cancer Centers of Nevada
Shared therapeutic areas:
Glenn Lesser, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
jianxing he, MD
The First Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
All 2 trials loaded